Related Experiment Video
Updated: Oct 28, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Heart Failure: Heart Failure With Preserved Ejection Fraction
1Department of Family Medicine at University of North Carolina at Chapel Hill School of Medicine, 590 Manning Drive, Chapel Hill, NC 27514.
Insights
Heart failure (HF) affects millions in the US, with rising numbers expected. New classifications like HF with preserved ejection fraction (HFpEF) emphasize symptom and comorbidity management for better patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure (HF) presents a significant public health challenge in the US, with high incidence and prevalence.
- Increasing age is a primary nonmodifiable risk factor for HF development.
- Modifiable risk factors including hypertension, diabetes, and ischemic heart disease require management to mitigate HF morbidity and mortality.
Purpose of the Study:
- To update understanding of heart failure classification and management strategies.
- To highlight the importance of current terminology, moving away from outdated terms like 'congestive heart failure'.
- To define current approaches to managing HF with preserved ejection fraction (HFpEF).
Main Methods:
- Classification of left-sided HF based on ejection fraction (EF).
- Definition of HF with preserved EF (HFpEF) for EF ≥ 50%.
- Definition of HF with reduced EF (HFrEF) for EF ≤ 40%.
Main Results:
- HFpEF management priorities include symptom control and managing comorbid conditions.
- Key management strategies for HFpEF involve fluid overload avoidance, optimized blood pressure control, and atrial fibrillation management.
- HFpEF diagnosis carries a substantial 5-year mortality rate (22%-65%), with cardiovascular causes accounting for the majority of deaths (51%-60%).
Conclusions:
- Current HF classification relies on EF, distinguishing HFpEF from HFrEF.
- Effective HFpEF management necessitates a focus on symptom relief and addressing underlying health issues.
- The high mortality associated with HFpEF underscores the need for continued research and improved therapeutic strategies.
Abstract:
The incidence and prevalence of heart failure (HF) in the United States are high, with an estimated 6.2 million cases, and these numbers are expected to increase. Age is a nonmodifiable risk factor for HF development. Hypertension, diabetes, and ischemic heart disease are modifiable risk factors that can be addressed to reduce the morbidity and mortality associated with HF. Improvements in understanding of the pathophysiology of HF have led to changes in terminology. Terms such as congestive heart failure, systolic heart failure, and diastolic heart failure should no longer be used. Currently, the ejection fraction (EF) is used to classify left-sided HF. Patients with classic HF symptoms and an EF of 50% or greater have HF with a preserved EF (HFpEF). Patients with an EF of 40% or less have HF with a reduced EF (HFrEF). Priorities in HFpEF management are symptom management and control of comorbid conditions. This includes avoidance of fluid overload, blood pressure control optimization, and atrial fibrillation management. The diagnosis of HFpEF is associated with a 22% to 65% 5-year mortality rate, with 51% to 60% of deaths due to cardiovascular causes.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management

